News

Carlyle Credit Income Fund's NAV Insights and Latest Developments

Carlyle Credit Income Fund's NAV Insights and Latest Developments

Understanding Carlyle Credit Income Fund's Latest NAV Report

Carlyle Credit Income Fund (NYSE: CCIF) has recently unveiled its unaudited net asset value (NAV) per common share, reporting this figure as $7.64. This information was shared through a filing with the Securities and Exchange Commission, indicating the fund's current fiscal status. The announcement is important for investors, offering a glimpse into the health and value of the fund.

The Significance of NAV Calculation

The NAV is a pivotal metric for investment funds, as it provides a clear picture of the company's overall worth. By dividing the total net asset value of the fund by the number of shares outstanding, investors can better understand their investment's value. The recent NAV per share figure underscores Carlyle Credit Income Fund's ongoing performance and offers investors insight into their potential returns.

Carlyle Credit Income Fund's Historical Context

This fund, formerly recognized as the Vertical Capital Income Fund, is incorporated in Delaware and proudly trades on the New York Stock Exchange under the ticker symbol CCIF. The company also offers preferred shares labeled under the ticker CCIAN, catering to a broader range of investors looking for diverse investment opportunities.

Exploring Recent Developments and Financial Performance

Carlyle Credit Income Fund remains active in the Collateralized Loan Obligation (CLO) marketplace, with reports confirming that it has maintained a quarterly dividend of $0.105 per share through November. This consistent dividend payout showcases the fund's commitment to rewarding its shareholders.

Moreover, the fund has engaged in a private placement of its 7.125% Series B Convertible Preferred Shares, which are expected to raise approximately $10.6 million. It is also in the process of executing a registered direct placement of 1,444,865 common shares, anticipated to generate around $11.5 million in proceeds. Such strategic movements demonstrate the fund's proactive approach to enhancing its financial position.

In terms of investment performance, Carlyle Credit Income Fund has made noteworthy strides, with new CLO investments amounting to $12.2 million. With an impressive weighted average GAAP yield of 19.5%, the fund's overall investment income for the third quarter reached $7.4 million. Additionally, the fund successfully raised $5.5 million through its At-The-Market (ATM) program. The fund's portfolio continues to perform robustly, exhibiting a GAAP yield of 20.26% based on its cost and a junior overcollateralization cushion of 4.17%.

Insights on Dividend Performance

Recent insights reveal that Carlyle Credit Income Fund boasts an attractive dividend yield of 15.05%, with its most recent ex-dividend date recorded as September 18, 2024. This data reinforces the fund's history of consistent dividend payments, having maintained this for 13 consecutive years—a testament to its commitment to delivering value to shareholders.

Market Performance and Stock Valuation

As of the latest update, Carlyle Credit Income Fund's stock price stood at $8.37, which represents 95.34% of its 52-week high. This suggests that the fund's performance has been solid in recent times. Positive returns further corroborate this strength, with total returns of 22.85% over the past year and 18.06% year-to-date, marking it as a noteworthy investment option.

Further Analysis Available

For investors looking for deeper insights and analysis, Carlyle Credit Income Fund has numerous resources available. These insights can help in making informed investment decisions, adding layers of understanding regarding the fund’s financial health and market performance.

Frequently Asked Questions

What is the current NAV per share for Carlyle Credit Income Fund?

The unaudited NAV per share for Carlyle Credit Income Fund is currently reported as $7.64.

What dividends has Carlyle Credit Income Fund been paying recently?

The fund has maintained a quarterly dividend of $0.105 per share through November.

How active is Carlyle Credit Income Fund in the CLO market?

Carlyle Credit Income Fund has recently engaged in CLO investments totaling $12.2 million, showcasing its active participation in this market.

What is the historical yield of Carlyle Credit Income Fund?

The fund currently boasts a dividend yield of 15.05%, reflecting its commitment to shareholder returns.

What has been the stock performance of Carlyle Credit Income Fund?

The stock price is at $8.37, representing 95.34% of its 52-week high, with positive total returns observed over the last year.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 38

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Medline's MedTrans Rodeo: Honoring Driver Excellence

Updated Category News Views 72

Rollin' Down the Road of Excellence In the world of healthcare logistics, Medline's MedTrans team isn't just steering trucks—they're steering safety culture and supply chain efficiency. This October, they wrapped up their fourth annual National Truck Rodeo in Mundelein, Illinois. And let me tell you, it was more than just a fancy event. It was about celebrating the real...

Continue Reading
Quest Diagnostics Faces Class Action After Data Breach

Updated Category News Views 4

Data Breach Rocks Quest Diagnostics October 2026 caught Quest Diagnostics in a bind they wish they could escape—a classic tech breach with personal info hanging out to dry. When a cyber ghost slipped into Quest's Quanum Lab Services Manager, it wasn't to deliver flowers. Nope, this unauthorized access was no friendly visit, forcing Quest to scream foul and play serious...

Continue Reading
Think Together Marks 20 Years of ASES Impact in CA

Updated Category News Views 77

Hands-on Learning: California's Bright Future Starts Here Who's ever thought a schoolyard's the same after three? Let me tell you, in California, it's staying alive and kicking, thanks to Think Together's whirlwind of celebrations for the After School Education and Safety (ASES) program. We're talking 450 schoolyard shindigs highlighting not just how far expanded learning...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 146

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 35

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 150

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading
Galien Recognizes Kerry for Transformative Global Health Work

Updated Category News Views 75

Kerry's Legacy: A Symbol of Global Unity In the ever-thickening jungle of geopolitics and global health, it's rare to find a beacon as steadfast as John Kerry. This year, The Galien Foundation saw fit to honor him with the 2026 Roy Vagelos Pro Bono Humanum Award for Global Health Equity. This ain't just some shiny trinket—it’s a testament to his lifetime of ripping...

Continue Reading
PZZA Faces Class Action: Strategic Shake-up or Misstep?

Updated Category News Views 10

Papa John's: Doughy Deceit or Strategic Misfire? Once in a while, a corporation trips over its own ambitious production line, and Papa John’s (NASDAQ:PZZA) is the latest contestant to make headlines for all the wrong reasons. Investors in this pizza powerhouse are being called to the courtroom as a class action lawsuit unfolds, marking a turbulent stage in the...

Continue Reading
Monterey Desalination Project: Costs, Challenges & Future

Updated Category News Views 19

Water Woes Dragging on in Monterey? Alright, let's dive into the nitty-gritty of this water supply saga in the Monterey Peninsula. If you're wondering why California American Water is hustling so hard, it's because the taps around here ain't running like they should. This mess has been stretching on for ages, with everyone thirsty for a sustainable answer. The Cost of...

Continue Reading

Top 5 Most Recently Viewed Articles

Axsome Therapeutics Reaches Settlement on Sunosi Patent Dispute

Updated Category News Views 100

Settlement Agreement Between Axsome Therapeutics and Hikma Axsome Therapeutics, Inc. (NASDAQ: AXSM), a forerunner in biopharmaceutical development, has recently announced a significant settlement agreement with Hikma Pharmaceuticals USA. This agreement resolves ongoing patent litigation concerning Sunosi (solriamfetol), Axsome's treatment for excessive daytime sleepiness....

Continue Reading
Cryptocurrency Market Stagnates as Analysts Forecast Drop

Updated Category News Views 174

Current Overview of Major Cryptocurrencies The leading cryptocurrencies are holding steady in their positions, with many traders observing a stable yet uneventful market environment. Recently, a feeling of optimism arose as stock markets showed signs of recovery amidst expectations of possible interest rate cuts in the near future. Market Status of Bitcoin and Ethereum...

Continue Reading
Discover the Meteor Profit App: Empower Your Trading Experience

Updated Category News Views 527

Revolutionizing Online Trading with Meteor Profit Meteor Profit has become a prominent name among investors seeking efficient and secure online trading platforms. This innovative tool connects users with licensed brokers, creating opportunities backed by advanced technology for users looking to maximize their trading experiences. What is Meteor Profit? Meteor Profit is a...

Continue Reading
Exciting Updates from Nasdaq Ahead of Q2 Financial Results

Updated Category News Views 125

Upcoming Nasdaq Investor Conference Call Nasdaq has set its sights on providing investors with critical insights into its financial performance for the second quarter of 2025. As one of the leading global technology firms operating in the capital markets, Nasdaq's updates are highly anticipated by stakeholders. Event Details Who Will Be Present: Nasdaq’s leadership...

Continue Reading
Smart for Life Faces Delisting from Nasdaq: A Challenging Journey

Updated Category News Views 136

Smart for Life's Delisting from Nasdaq: What You Need to Know Recently, Smart for Life, Inc. encountered a significant setback by being officially delisted from The Nasdaq Capital Market. This decision has raised concerns and initiated discussions about the company's adherence to important regulations and listing requirements. What Caused the Delisting? The delisting took...

Continue Reading